Small Animal Imaging (In Vivo) Market: Emerging Trends and Opportunities 2024-2032

[HealthInsights]

The global Small Animal Imaging (In Vivo) Market is on a strong growth trajectory, with a recent analysis by SNS Insider revealing a market valuation of USD 1.16 billion in 2023, and projections indicating it will more than double, reaching USD 2.27 billion by 2032. This expansion, at a CAGR of 7.76% during the forecast period from 2024 to 2032, underscores the rising importance of non-invasive imaging technologies in biomedical research and drug development.

The surge in demand is being fueled by increasing investment in preclinical research, growing adoption of molecular imaging, and technological advances in imaging modalities. Small animal imaging (in vivo) is becoming an essential tool for researchers and pharmaceutical companies seeking deeper insights into disease mechanisms, treatment efficacy, and drug metabolism—without the need for invasive methods or sacrificing animals during studies.

Key Drivers of Market Growth

One of the most significant factors driving this market is the rapid progress in molecular imaging technologies, particularly in modalities like MRI, PET, SPECT, CT, and optical imaging. These tools allow for real-time visualization of biological processes in small animals, offering a critical bridge between in vitro findings and clinical applications.

Further supporting market expansion is the increasing use of animal models in cancer, neurology, cardiology, and infectious disease research. With the pharmaceutical industry under pressure to reduce the cost and duration of drug development, small animal imaging enables quicker, safer, and more efficient evaluations of new therapies before advancing to human trials.

Government and private sector funding for preclinical and translational research has also been instrumental. Academic institutions, contract research organizations (CROs), and biotech companies are deploying advanced imaging systems to increase productivity, reduce animal usage, and comply with ethical standards in laboratory research.

Market Segmentation Insights

The Small Animal Imaging (In Vivo) Market is segmented by modality, application, and end-user. Among the imaging modalities, micro-CT and micro-PET are currently leading the market due to their precision, resolution, and ease of integration into laboratory workflows.

In terms of application, oncology research continues to dominate, accounting for a major share of the overall market. This is attributed to the growing global cancer burden and the critical need for advanced imaging techniques that can track tumor progression, metastasis, and therapeutic response in animal models.

Academic and research institutes represent the largest end-user segment, followed closely by pharmaceutical and biotechnology companies. The increased outsourcing of preclinical studies to CROs is also creating new growth opportunities for vendors in the market.

For more detailed insights, visit: Small Animal Imaging (In Vivo) Market Share

Regional Overview

North America continues to lead the global market due to the presence of major research institutions, established pharmaceutical companies, and robust funding infrastructure. However, Asia-Pacific is emerging as a high-growth region, driven by rapid development in biotech sectors across China, India, and South Korea, alongside rising government investment in life sciences research.

Europe, too, remains a strong player, with collaborative research programs and funding from organizations such as Horizon Europe and the European Molecular Biology Laboratory (EMBL).

Competitive Landscape

The small animal imaging market features several prominent players, including Bruker Corporation, PerkinElmer Inc., FUJIFILM Holdings Corporation, Mediso Ltd., and MILabs B.V. These companies are focusing on innovation, strategic partnerships, and expanding product portfolios to stay ahead in a competitive and technology-driven market.

Technological innovation remains a key differentiator, with companies investing heavily in hybrid imaging systems and software platforms for image analysis, data management, and AI-driven diagnostics.

Future Outlook

Looking ahead, the market is expected to benefit from continued advancements in AI integration, image processing, and data analytics, which will enhance image clarity, reduce noise, and streamline interpretation. Additionally, the growing shift toward personalized medicine and precision research will likely spur further investment in in vivo imaging solutions.

As regulatory bodies push for greater transparency and ethical standards in animal testing, in vivo imaging will remain pivotal to reducing the number of animals used while improving the quality and reproducibility of research outcomes.

---

About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to provide you with current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Akash Anand – Head of Business Development & Strategy
📧 [e-mail]
📞 [phone] (US) | [phone] (IND)